Roche's Sequencing Business Grows 12 Percent YTD as Applied Science Sales Shrink in Q3

Roche said it has seen "robust uptake" in the European Union and Asia Pacific for the 454 GS Junior sequencer, a benchtop sequencer launched in May that is geared at small laboratories.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.